Efficacy of leflunomide as a steroid-sparing agent in treatment of Indian giant cell arteritis patients: A 2-year follow-up study.
Sign Up to like & getrecommendations! Published in 2022 at "International journal of rheumatic diseases"
DOI: 10.1111/1756-185x.14319
Abstract: OBJECTIVES To evaluate the effectiveness of leflunomide as a steroid-sparing agent among Indian patients with giant cell arteritis (GCA) and to assess the changes of "halo sign" within affected arteries, detected ultrasonographically, after remission. METHODS… read more here.
Keywords: sparing agent; giant cell; steroid sparing; study ... See more keywords
Performance of leflunomide as a steroid-sparing agent in giant cell arteritis: A single-center, open-label study
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2022.1069013
Abstract: Background The management of giant cell arteritis (GCA) remains challenging and many patients require prolonged glucocorticoid treatment due to high disease relapse rates. We aimed to evaluate the role of leflunomide as a steroid-sparing agent… read more here.
Keywords: leflunomide steroid; leflunomide; giant cell; group ... See more keywords